XTUIT PHARMACEUTICALS, INC.
Profile
Company Names
XTUIT PHARMACEUTICALS, INC.
Addresses
35 GATEHOUSE DRIVE, SUITE A1, WALTHAM, MA 02451
1000 WINTER STREET, SUITE 3350, WALTHAM, MA 02451
Phone Numbers
617-588-3770
781-290-0770
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$23,525,512.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2014-11-20
$22,016,999.00
$22,016,999.00
$0.00
Equity
1
2014-01-17
$1,508,513.00
$1,508,513.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALAN
CRANE
EXECUTIVE OFFICER, DIRECTOR
CERULEAN PHARMA INC.
| PARASOL THERAPEUTICS INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| VISTERRA, INC.
| EXPERIMENT FUND, LLC
| OCULAR THERAPEUTIX, INC
| CALORICS, INC.
| XTUIT PHARMACEUTICALS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| PANDION THERAPEUTICS, INC.
| SEISMIC THERAPEUTIC, INC.
EDWARD
FREEDMAN
EXECUTIVE OFFICER
ROBERT
LANGER
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ALSERES PHARMACEUTICALS INC /DE
| ECHO THERAPEUTICS, INC.
| MICELL TECHNOLOGIES INC
| CERULEAN PHARMA INC.
| HUMACYTE INC
| COMBINENT BIOMEDICAL SYSTEMS, INC.
| TARIS BIOMEDICAL INC
| KALA PHARMACEUTICALS, INC.
| FIBROCELL SCIENCE, INC.
| PREDICTIVE BIOSCIENCES, INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| SEMPRUS BIOSCIENCES CORP
| LIQUIDX, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| SELECTA BIOSCIENCES INC
| STEMNION, INC.
| 480 BIOMEDICAL, INC.
| LIVING PROOF INC
| DX BIOSCIENCES, INC.
| MODERNA LLC
| HUMACYTE, INC
| XTUIT PHARMACEUTICALS, INC.
| SQZ BIOTECHNOLOGIES CO
| NOVEOME BIOTHERAPEUTICS, INC.
| LYNDRA, INC.
| MODERNA THERAPEUTICS, INC.
| VERSEAU THERAPEUTICS, INC.
| FREQUENCY THERAPEUTICS, INC.
| SUONO BIO, INC.
| COMBINED THERAPEUTICS, INC.
| HUMACYTE, INC.
| SEER BIOSCIENCES, INC.
| LANDSDOWNE LABS, LLC
| LIKEMINDS, INC./DE
| TARVEDA THERAPEUTICS, INC.
| LUMINOPIA, INC.
| LYRA THERAPEUTICS, INC.
| ABPRO CORP
| GLYMPSE BIO, INC.
| EPIBONE, INC.
| TEAL BIO, INC.
| ZWI THERAPEUTICS, INC.
| LYNDRA THERAPEUTICS, INC.
| KENDALL CAPITAL PARTNERS I, L.P.
| BILAYER THERAPEUTICS, INC.
| XENTER, INC.
| VIVTEX CORP
| SYNTIS BIO, INC.
| OMNIPULSE BIOSCIENCES, INC.
DAVID
MOTT
DIRECTOR
3-V BIOSCIENCES, INC.
| TESARO, INC.
| ARDELYX, INC.
| ZYNGENIA, INC.
| OMTHERA PHARMACEUTICALS, INC.
| MERSANA THERAPEUTICS INC
| CYDAN, LLC
| EDIMER PHARMACEUTICALS, INC.
| PROSENSA HOLDING N.V.
| ADAPTIMMUNE LTD
| MERSANA THERAPEUTICS, INC.
| XTUIT PHARMACEUTICALS, INC.
| IMARA INC.
| COMPLEXA INC.
| CYDAN II, INC.
| TIBURIO THERAPEUTICS INC.
GARRY
NICHOLSON
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

